Literature DB >> 15585963

Establishment and characterization of four canine melanoma cell lines.

Kaori Inoue1, Emi Ohashi, Tsuyoshi Kadosawa, Sung-Hyeok Hong, Satoru Matsunaga, Manabu Mochizuki, Ryohei Nishimura, Nobuo Sasaki.   

Abstract

Four canine melanoma cell lines were established from the subcutaneous, oral gingival and mucosal melanoma tissues at the primary and metastatic sites. These cell lines were designated as CMeC-1, CMeC-2, KMeC and LMeC. The cells were spindles in shape, similar to that of primary tumor cells. The doubling times of these cells ranged from 34.1 +/- 5.61 to 57.9 +/- 3.28 hr and their chromosome number ranged from 46 to 80. When transplanted into nude mice, CMeC-1 and LMeC produced tumors, whereas CMeC-2 and KMeC did not. The morphology of the tissue formed by xenotransplantation of these cells was similar to their primary tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15585963     DOI: 10.1292/jvms.66.1437

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  22 in total

1.  Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines.

Authors:  Kyoung-Won Seo; Ye-Rin Coh; Robert B Rebhun; Jin-Ok Ahn; Sei-Myung Han; Hee-Woo Lee; Hwa-Young Youn
Journal:  Res Vet Sci       Date:  2014-03-20       Impact factor: 2.534

2.  Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.

Authors:  Ursa Lampreht; Urska Kamensek; Monika Stimac; Gregor Sersa; Natasa Tozon; Masa Bosnjak; Andreja Brozic; Geraldo Gileno de Sá Oliveira; Takayuki Nakagawa; Kohei Saeki; Maja Cemazar
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

3.  Bystander Effect Induced by Electroporation is Possibly Mediated by Microvesicles and Dependent on Pulse Amplitude, Repetition Frequency and Cell Type.

Authors:  Ajda Prevc; Apolonija Bedina Zavec; Maja Cemazar; Veronika Kloboves-Prevodnik; Monika Stimac; Vesna Todorovic; Primoz Strojan; Gregor Sersa
Journal:  J Membr Biol       Date:  2016-07-01       Impact factor: 1.843

4.  The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma.

Authors:  Shuhei Enjoji; Ryotaro Yabe; Nobuyuki Fujiwara; Shunya Tsuji; Michael P Vitek; Takuya Mizuno; Takayuki Nakagawa; Tatsuya Usui; Takashi Ohama; Koichi Sato
Journal:  J Vet Med Sci       Date:  2015-06-11       Impact factor: 1.267

5.  Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers.

Authors:  Hiroto Takeuchi; Satoru Konnai; Naoya Maekawa; Erina Minato; Yoshiki Ichikawa; Atsushi Kobayashi; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
Journal:  Front Vet Sci       Date:  2020-06-11

6.  Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.

Authors:  Zacharie Segaoula; Aline Primot; Frederic Lepretre; Benoit Hedan; Emmanuel Bouchaert; Kevin Minier; Laurent Marescaux; François Serres; Sylvie Galiègue-Zouitina; Catherine André; Bruno Quesnel; Xavier Thuru; Dominique Tierny
Journal:  BMC Cancer       Date:  2018-12-04       Impact factor: 4.430

7.  The oncolytic effects of reovirus in canine solid tumor cell lines.

Authors:  Masaya Igase; Chung Chew Hwang; Matt Coffey; Masaru Okuda; Shunsuke Noguchi; Takuya Mizuno
Journal:  J Vet Med Sci       Date:  2015-01-16       Impact factor: 1.267

8.  Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-β and treatment with cisplatin in a xenograft mouse model for canine melanoma.

Authors:  Jin ok Ahn; Hee woo Lee; Kyoung won Seo; Sung keun Kang; Jeong chan Ra; Hwa young Youn
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma.

Authors:  Masaya Igase; Shusaku Shibutani; Yosuke Kurogouchi; Noriyuki Fujiki; Chung Chew Hwang; Matt Coffey; Shunsuke Noguchi; Yuki Nemoto; Takuya Mizuno
Journal:  Mol Ther Oncolytics       Date:  2019-08-28       Impact factor: 7.200

10.  Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours.

Authors:  Maria Mellinas-Gomez; Victoria J Spanswick; Solange R Paredes-Moscosso; Matthew Robson; R Barbara Pedley; David E Thurston; Stephen J Baines; Anneliese Stell; John A Hartley
Journal:  BMC Vet Res       Date:  2015-08-19       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.